Engineered skin substitute (Amarantus Bioscience)

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug NameEngineered skin substitute (Amarantus Bioscience)
Drug Alias NameHuman skin replacementCultured skin substitutePermaDermESS-W
ClassificationBiologics
Mechanisms of ActionTissue replacements
TargetsNot applicable
Therapy Area/IndicationsBurns
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesLonza
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAmarantus Bioscience Holdings Inc
Active IndicationsN/A
Inactive IndicationsBurns

Other Information

ATC CodeN/A
Related LinksN/A